Google scholar roberts jl, fiedler v, imperato-mcginley j, whiting d, olsen e, shupack j, stough d, devillez r, rietschel r, savin r, bergfeld w, swinehart j, funicella t, hordinsky m, lowe n, katz i, lucky a, drake l, price vh, weiss d, whitmore e, millikan l, muller s, gencheff c, et al clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.